KRAS mutations are an abnormality more commonly seen in lung cancer patients who smoke or previously smoked. For decades, despite many attempts, KRAS-mutated lung cancer did not have a targeted ...

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

They assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens. Data originated from approximately 280 US cancer ...

In addition, active KRAS may engage non-RAF effectors in specific ... 3.4 million patients who receive a diagnosis of RAS-mutant cancer each year.

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will ...

Deep learning–powered analysis of tumor-infiltrating lymphocytes (TILs) in colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does ...

2025 Potential U.S. commercial launch in recurrent KRAS mutant LGSOC planned for mid-2025 RAMP 205 trial in 1L metastatic ...

Analysis of tumor microenvironmental features of primary and synchronous liver metastases from patients with colorectal cancer using a deep learning algorithm. Real-world analysis of the impact of ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...